These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12393040)

  • 21. Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis.
    Holland M; Takada K; Okumoto T; Takahashi N; Kato K; Adu D; Ben-Smith A; Harper L; Savage CO; Jefferis R
    Clin Exp Immunol; 2002 Jul; 129(1):183-90. PubMed ID: 12100039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New developments in the treatment of Wegener's granulomatosis, polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome.
    Langford CA; Sneller MC
    Curr Opin Rheumatol; 1997 Jan; 9(1):26-30. PubMed ID: 9110130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):85-87. PubMed ID: 29185957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different gender-associated genotype risks of Wegener's granulomatosis and microscopic polyangiitis.
    Bártfai Z; Gaede KI; Russell KA; Muraközy G; Müller-Quernheim J; Specks U
    Clin Immunol; 2003 Dec; 109(3):330-7. PubMed ID: 14697748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Systemic ANCA-associated vasculitis--diagnosis and therapy].
    Eisenberger U; Hess C
    Ther Umsch; 2008 May; 65(5):295-301. PubMed ID: 18622935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary systemic vasculitis: clinical features and mortality.
    Lane SE; Watts RA; Shepstone L; Scott DG
    QJM; 2005 Feb; 98(2):97-111. PubMed ID: 15655098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming growth factor-beta (TGF-beta) expression and interaction with proteinase 3 (PR3) in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
    Csernok E; Szymkowiak CH; Mistry N; Daha MR; Gross WL; Kekow J
    Clin Exp Immunol; 1996 Jul; 105(1):104-11. PubMed ID: 8697616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vasculitis management: discovery of antineutrophil cytoplasmic antibodies (ANCA)].
    Guillevin L
    Presse Med; 2007 May; 36(5 Pt 2):843-4. PubMed ID: 17449373
    [No Abstract]   [Full Text] [Related]  

  • 29. Microscopic polyangiitis (microscopic polyarteritis) with late emergence of generalised Wegener's granulomatosis.
    Bosch X
    Ann Rheum Dis; 1999 Oct; 58(10):644-7. PubMed ID: 10491365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
    Surendran S; Gundappa C; Gandhi A; Kurien AA; Fernando E
    Saudi J Kidney Dis Transpl; 2017; 28(3):639-644. PubMed ID: 28540906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antineutrophil cytoplasmic antibodies (ANCA) and abnormal angiograms in polyarteritis nodosa and Churg-Strauss syndrome: indications for the diagnosis of microscopic polyangiitis.
    Guillevin L; Lhote F; Brauner M; Casassus P
    Ann Med Interne (Paris); 1995; 146(8):548-50. PubMed ID: 8734079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Sørensen diagnostic criteria in the classification of systemic vasculitis.
    Lane SE; Watts RA; Barker TH; Scott DG
    Rheumatology (Oxford); 2002 Oct; 41(10):1138-41. PubMed ID: 12364633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of patients with small-vessel vasculitis admitted to a medical ICU.
    Khan SA; Subla MR; Behl D; Specks U; Afessa B
    Chest; 2007 Apr; 131(4):972-6. PubMed ID: 17426197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Respiratory system involvement in systemic vasculitides.
    Manganelli P; Fietta P; Carotti M; Pesci A; Salaffi F
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S48-59. PubMed ID: 16859597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [ANCA-associated vasculitis (Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis). 3. Therapeutic procedure].
    Reinhold-Keller E; Tatsis E; Gross WL
    Z Rheumatol; 1995; 54(5):303-9. PubMed ID: 8578886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature.
    Sørensen SF; Slot O; Tvede N; Petersen J
    Ann Rheum Dis; 2000 Jun; 59(6):478-82. PubMed ID: 10834866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature.
    Rothschild PR; Pagnoux C; Seror R; Brézin AP; Delair E; Guillevin L
    Semin Arthritis Rheum; 2013 Apr; 42(5):507-14. PubMed ID: 23270762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency and patterns of subclinical cognitive impairment in patients with ANCA-associated small vessel vasculitides.
    Mattioli F; Capra R; Rovaris M; Chiari S; Codella M; Miozzo A; Gregorini G; Filippi M
    J Neurol Sci; 2002 Mar; 195(2):161-6. PubMed ID: 11897248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Churg-Strauss syndrome.
    Greco A; Rizzo MI; De Virgilio A; Gallo A; Fusconi M; Ruoppolo G; Altissimi G; De Vincentiis M
    Autoimmun Rev; 2015 Apr; 14(4):341-8. PubMed ID: 25500434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antineutrophil cytoplasmic antibody(ANCA)].
    Yoshida M
    Rinsho Byori; 2003 Jul; 51(7):644-8. PubMed ID: 12924248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.